Effect of New-Onset Left Bundle Branch Block After Transcatheter Aortic Valve Implantation (CoreValve) on Mortality,

José López-Aguilera1, José M Segura Saint-Gerons1, Francisco Mazuelos Bellido1

  • 1Reina Sofia University Hospital, Maimonides Institute for Biomedical Research, University of Cordoba, Córdoba, Spain.

Insights

New left bundle branch block (LBBB) after transcatheter aortic valve implantation (TAVI) does not increase long-term mortality or heart failure hospitalizations. This study found no significant difference in pacemaker needs between patients with and without new-onset LBBB post-TAVI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • New-onset conduction disturbances, particularly left bundle branch block (LBBB), are frequent after transcatheter aortic valve implantation (TAVI).
  • The clinical significance of new-onset LBBB following TAVI regarding long-term outcomes remains debated.

Purpose of the Study:

  • To investigate the long-term clinical impact of new-onset LBBB after TAVI.
  • To assess the association between new-onset LBBB and mortality, heart failure hospitalizations, and pacemaker implantation rates.

Main Methods:

  • A cohort of 153 patients undergoing CoreValve implantation for severe aortic stenosis was analyzed.
  • Patients were divided into two groups: persistent new-onset LBBB (n=80) and no conduction disturbances (n=73).
  • Follow-up included assessments at 1 month, 6 months, 12 months, and annually thereafter, with a mean follow-up of 32 months.

Main Results:

  • Persistent new-onset LBBB was observed in 36% of patients immediately post-TAVI.
  • No significant differences were found in long-term mortality (39% vs 48%) or re-hospitalizations for heart failure (11% vs 16%) between groups.
  • The incidence of late pacemaker implantation was similar in both groups (10% vs 13%).

Conclusions:

  • New-onset LBBB after CoreValve TAVI is not associated with an increased risk of late pacemaker implantation.
  • The study suggests that new-onset LBBB following TAVI does not adversely affect long-term mortality or heart failure re-hospitalization rates.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
413
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
497
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
530
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
340
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
977